This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Razvi S, Jabbar A, Pingitore A, et al. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol. 2018;71:1781–1796. doi: 10.1016/j.jacc.2018.02.045RazviSJabbarAPingitoreAThyroid Hormones and Cardiovascular Function and DiseasesJ Am Coll Cardiol2018711781179610.1016/j.jacc.2018.02.045Open DOISearch in Google Scholar
Shahid MA, Ashraf MA, Sharma S. Physiology, Thyroid Hormone. Treasure Island (FL): StatPearls; https://www.ncbi.nlm.nih.gov/books/NBK500006/ (5 Jun 2023)ShahidMAAshrafMASharmaSPhysiology, Thyroid HormoneTreasure Island (FL)StatPearlshttps://www.ncbi.nlm.nih.gov/books/NBK500006/ (5 Jun 2023)Search in Google Scholar
Nappi A, Murolo M, Sagliocchi S, et al. Selective Inhibition of Genomic and Non-Genomic Effects of Thyroid Hormone Regulates Muscle Cell Differentiation and Metabolic Behavior. Int J Mol Sci. 2021;22(13):7175. doi: 10.3390/ijms22137175NappiAMuroloMSagliocchiSSelective Inhibition of Genomic and Non-Genomic Effects of Thyroid Hormone Regulates Muscle Cell Differentiation and Metabolic BehaviorInt J Mol Sci20212213717510.3390/ijms22137175Open DOISearch in Google Scholar
Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014;26(6):296–309. doi: 10.1016/j.arteri.2014.07.003Vargas-UricoecheaHBonelo-PerdomoASierra-TorresCHEffects of thyroid hormones on the heartClin Investig Arterioscler201426629630910.1016/j.arteri.2014.07.003Open DOISearch in Google Scholar
von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A. The impact of thyroid hormone dysfunction on ischemic heart disease. Endocr Connect. 2019;8(5):R76–R90. doi: 10.1530/EC-19-0096von HafeMNevesJSValeCBorges-CanhaMLeite-MoreiraAThe impact of thyroid hormone dysfunction on ischemic heart diseaseEndocr Connect201985R76R9010.1530/EC-19-0096Open DOISearch in Google Scholar
Arslan A, Altay H. Graves’ Disease and Cardiac Complications [Internet]. Graves’ Disease. IntechOpen; 2021. doi: 10.5772/intechopen.97128ArslanAAltayHGraves’ Disease and Cardiac Complications [Internet]. Graves’ DiseaseIntechOpen202110.5772/intechopen.97128Open DOISearch in Google Scholar
López Ortega JM, Martínez PS, Acevedo-León D, Capell NE. Anti-TSH receptor antibodies (TRAb): Comparison of two third-generation automated immunoassays broadly used in clinical laboratories and results interpretation. PLoS One. 2022;17(7):e0270890. doi: 10.1371/journal.pone.0270890López OrtegaJMMartínezPSAcevedo-LeónDCapellNEAnti-TSH receptor antibodies (TRAb): Comparison of two third-generation automated immunoassays broadly used in clinical laboratories and results interpretationPLoS One2022177e027089010.1371/journal.pone.0270890Open DOISearch in Google Scholar
Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. doi: 10.1097/HJH.0000000000003480ManciaGKreutzRBrunströmM2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)J Hypertens202341121874207110.1097/HJH.0000000000003480Open DOISearch in Google Scholar
Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J. 2018;7(4):167–186. doi: 10.1159/000490384KahalyGJBartalenaLHegedüsL2018 European Thyroid Association Guideline for the Management of Graves’ HyperthyroidismEur Thyroid J20187416718610.1159/000490384Open DOISearch in Google Scholar
Abdi H, Amouzegar A, Azizi F. Antithyroid Drugs. Iran J Pharm Res. 2019 Fall;18(Suppl1):1–12. doi: 10.22037/ijpr.2020.112892.14005AbdiHAmouzegarAAziziFAntithyroid DrugsIran J Pharm Res2019Fall18Suppl111210.22037/ijpr.2020.112892.14005Open DOISearch in Google Scholar
Ngassam E, Azabji-Kenfack M, Tankeu AT, et al. Heart rate variability in hyperthyroidism on sub Saharan African patients: a case–control study. BMC Res Notes. 2018;11(1):814. doi: 10.1186/s13104-018-3922-4NgassamEAzabji-KenfackMTankeuATHeart rate variability in hyperthyroidism on sub Saharan African patients: a case–control studyBMC Res Notes201811181410.1186/s13104-018-3922-4Open DOISearch in Google Scholar
Kotadia ID, Williams SE, O'Neill M. Supraventricular tachycardia: An overview of diagnosis and management. Clin Med. 2020;20(1):43–47. doi: 10.7861/clinmed.cme.20.1.3KotadiaIDWilliamsSEO'NeillMSupraventricular tachycardia: An overview of diagnosis and managementClin Med2020201434710.7861/clinmed.cme.20.1.3Open DOISearch in Google Scholar
Henning A, Krawiec C. Sinus Tachycardia. In: StatPearls [Internet]. Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK553128/ (5 Mar 2023)HenningAKrawiecCSinus TachycardiaIn:StatPearls [Internet]Treasure Island (FL)https://www.ncbi.nlm.nih.gov/books/NBK553128/ (5 Mar 2023)Search in Google Scholar
Navarro-Navajas A, Cruz JD, Ariza-Ordoñez N, et al. Cardiac manifestations in hyperthyroidism. Rev Cardiovasc Med. 2022;23(4):135–136. doi: 10.31083/j.rcm2304136Navarro-NavajasACruzJDAriza-OrdoñezNCardiac manifestations in hyperthyroidismRev Cardiovasc Med202223413513610.31083/j.rcm2304136Open DOISearch in Google Scholar
Brugada J, Katritsis DG, Arbelo E, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655–720. doi: 10.1093/eurheartj/ehz467BrugadaJKatritsisDGArbeloEESC Scientific Document Group2019 ESC Guidelines for the management of patients with supraventricular tachycardiaEur Heart J202041565572010.1093/eurheartj/ehz467Open DOISearch in Google Scholar
Elias RM, Dean DS, Barsness GW. Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience ISRN Endocrinol. 2012;2012:325092. doi: 10.5402/2012/325092EliasRMDeanDSBarsnessGWHepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experienceISRN Endocrinol2012201232509210.5402/2012/325092Open DOISearch in Google Scholar
Abdulrahman RM, Delgado V, Ng AC, et al. Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging. Eur J Endocrinol. 2010;163(3):435–441. doi: 10.1530/EJE-10-0328AbdulrahmanRMDelgadoVNgACAbnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imagingEur J Endocrinol2010163343544110.1530/EJE-10-0328Open DOISearch in Google Scholar
Lanspa MJ, Shahul S, Hersh A, et al. Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients. Ann Intensive Care. 2017;7(1):17. doi: 10.1186/s13613-017-0240-2LanspaMJShahulSHershAAssociations among left ventricular systolic function, tachycardia, and cardiac preload in septic patientsAnn Intensive Care2017711710.1186/s13613-017-0240-2Open DOISearch in Google Scholar